Activity

Filter

Cancel
Date Panel Item Activity
16 actions
Genetic Epilepsy v1.33 SPATA5 Zornitza Stark Marked gene: SPATA5 as ready
Genetic Epilepsy v1.33 SPATA5 Zornitza Stark Added comment: Comment when marking as ready: New HGNC approved name is AFG2A
Genetic Epilepsy v1.33 SPATA5 Zornitza Stark Gene: spata5 has been classified as Green List (High Evidence).
Genetic Epilepsy v1.33 SPATA5 Zornitza Stark Tag new gene name tag was added to gene: SPATA5.
Genetic Epilepsy v0.1395 SPATA5L1 Zornitza Stark Phenotypes for gene: SPATA5L1 were changed from Intellectual disability; spastic-dystonic cerebral palsy; epilepsy; hearing loss to Neurodevelopmental disorder with hearing loss and spasticity, MIM# 619616
Genetic Epilepsy v0.1394 SPATA5L1 Zornitza Stark reviewed gene: SPATA5L1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurodevelopmental disorder with hearing loss and spasticity, MIM# 619616; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Genetic Epilepsy v0.1371 SPATA5L1 Zornitza Stark Marked gene: SPATA5L1 as ready
Genetic Epilepsy v0.1371 SPATA5L1 Zornitza Stark Gene: spata5l1 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1371 SPATA5L1 Zornitza Stark Classified gene: SPATA5L1 as Green List (high evidence)
Genetic Epilepsy v0.1371 SPATA5L1 Zornitza Stark Gene: spata5l1 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.1370 SPATA5L1 Paul De Fazio gene: SPATA5L1 was added
gene: SPATA5L1 was added to Genetic Epilepsy. Sources: Literature
Mode of inheritance for gene: SPATA5L1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SPATA5L1 were set to 34626583
Phenotypes for gene: SPATA5L1 were set to Intellectual disability; spastic-dystonic cerebral palsy; epilepsy; hearing loss
Review for gene: SPATA5L1 was set to GREEN
gene: SPATA5L1 was marked as current diagnostic
Added comment: 47 individuals from 26 unrelated families from various ethnicities with biallelic variants reported. Phenotypes include ID, hearing impairment, movement disorder, abnormal MRI, hypotonia, visual impairment, epilepsy, and microcephaly.

In 25 patients for whom full phenotype datasets were available, 13 had epilepsy.
Sources: Literature
Genetic Epilepsy v0.473 SPATA5 Zornitza Stark Marked gene: SPATA5 as ready
Genetic Epilepsy v0.473 SPATA5 Zornitza Stark Gene: spata5 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.473 SPATA5 Zornitza Stark Classified gene: SPATA5 as Green List (high evidence)
Genetic Epilepsy v0.473 SPATA5 Zornitza Stark Gene: spata5 has been classified as Green List (High Evidence).
Genetic Epilepsy v0.472 SPATA5 Zornitza Stark gene: SPATA5 was added
gene: SPATA5 was added to Genetic Epilepsy. Sources: Expert list
Mode of inheritance for gene: SPATA5 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: SPATA5 were set to 27246907; 29343804; 26299366
Phenotypes for gene: SPATA5 were set to Epilepsy, hearing loss, and mental retardation syndrome, MIM# 616577
Review for gene: SPATA5 was set to GREEN
gene: SPATA5 was marked as current diagnostic
Added comment: More than 15 families have been reported in multiple publications. Clinical features include intellectual disability, epilepsy, microcephaly and hearing loss. May present as epileptic encephalopathy/epilepsy in the first year of life prior to onset of obvious developmental delay.
Sources: Expert list